Skip to main content
Caplight Logo









MedySapiens

MedySapiens

Private
SeoulHealthcare & Life Scienceshttps://medysapiens.com/en

Last Round

Series B

Jul 1, 2026

Total Funding Raised

$7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MedySapiens is a biotechnology company that develops AI-powered diagnostic solutions for the early detection of rare genetic diseases in newborns.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

genomic data analysisrare disease diagnosisbioinformaticsneonatal diagnosticsclinical decision supportprecision medicinenext-generation sequencingNGSgenetic testinggenomics AImedical AIvariant interpretationclinical genomicsgenomic medicinedigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedySapiens Comparables

Compare MedySapiens with similar companies based on industry and business-model similarity.

MedySapiens comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
enGenome
84%
Breakthrough Genomics
82%
SeqOne
78%

MedySapiens Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 1, 2026
Series AFeb 1, 2022
Pre SeedAug 27, 2019
SeedOct 26, 2018

Key People

Founding team and executive leadership

Taehyuk Kwon

COO

Executive Team

MedySapiens Investors

Notable investors and investment history

MedySapiens investors
InvestorRounds
L&S Venture CapitalSeries A
Vision CreatorSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Completed a Series B funding round.

  • May 13, 2026

    Monthly visitors increased 518% MoM, reaching 2.2K.

MedySapiens Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MedySapiens Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MedySapiens's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range13
Year Founded2016
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?